"10.1371_journal.pone.0135945","plos one","2015-08-25T00:00:00Z","Kimberly H Harrington; Chelsea J Gudgeon; George S Laszlo; Kathryn J Newhall; Angus M Sinclair; Stanley R Frankel; Roman Kischel; Guang Chen; Roland B Walter","Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Amgen, Inc., Seattle, Washington, United States of America; Amgen, Inc., Thousand Oaks, California, United States of America; Amgen, Inc., Rockville, Maryland, United States of America; Amgen Research (Munich) GmbH, Munich, Germany; Department of Medicine, Division of Hematology, University of Washington, Seattle, Washington, United States of America; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America","Conceived and designed the experiments: RBW. Performed the experiments: KHH CJG GSL. Analyzed the data: RBW KHH CJG GSL KJN AMS SRF RK GC. Contributed reagents/materials/analysis tools: KJN AMS SRF RK. Wrote the paper: RBW KHH CJG GSL KJN AMS SRF RK GC. Statistical analyses: GC.","The authors of this manuscript have read the journals policy and have the following competing interests: This work was supported by a research contract from Amgen, Inc. (to RBW). KJN, AMS, SRF, RK, and GC are employees of Amgen, Inc. CJG, KHH, and GSL declare no conflicts of interest. RBW has received research funding from Amgen, Inc. and Seattle Genetics, Inc., and has been a consultant for Seattle Genetics, Inc., Covagen AG, Amphivena Therapeutics, Inc., and AstraZeneca, Inc. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","08","Kimberly H Harrington","KHH",9,TRUE,1,3,9,9,TRUE,TRUE,FALSE,0,NA,FALSE
